M.D.
Neurosurgeon; Heritage Provider Network Professor in Gene Therapy
2000, Fellow, American College of Surgeons
1998, American Board of Neurological Surgery
1996, State of Wisconsin
1990, State of California
1985-1989, M.D., University of California Los Angeles School of Medicine, Los Angeles, CA
1980-1984, Bachelor of Science, Division of Biochemistry, University of California Los Angeles, Los Angeles, CA
1990-1996, Resident, Division of Neurological Surgery, University of California Los Angeles, Los Angeles, CA
1989-1990, Intern, Department of Surgery, University of California Los Angeles, Los Angeles, CA
2018-present, The Heritage Provider Network Professor in Gene Therapy, City of Hope, Duarte, CA
2011-present, Beckman Research Institute Board of Directors, Beckman Research Institute of City of Hope, Duarte, CA
2011-2020, Vice Chair, Department of Surgery City of Hope, Duarte, CA
2012-present, Chair, Faculty Senate Executive Committee Beckman Research Institute of City of Hope, Duarte CA
2005-present, Professor and Chief, Division of Neurosurgery, City of Hope, Duarte, CA
2005-2009, Associate Professor, Chief Division of Neurosurgery, City of Hope, Duarte, CA
2005-present, Co-Director, Brain Tumor Program, City of Hope, Duarte, CA
2004-2005, Member, Cellular and Molecular Pathology Training Program, University of Wisconsin-Madison, Madison, WI
2003-2005, Vice-Chair, Academic Affairs, Department of Neurological Surgery, University of Wisconsin-Madison, Madison, WI
2002 - 2005, Associate Professor (Tenure), Department of Neurological Surgery, University of Wisconsin-Madison, Madison, WI
1996-2005, Member, University of Wisconsin Comprehensive Cancer Center, Immunology/Biological Therapy Program
1996-2005, Member, University of Wisconsin Comprehensive Cancer Center, Immunology/Biological Therapy Program
1996-2005, Director, Comprehensive Brain Tumor Program, University of Wisconsin-Madison, Madison, WI
1996-2002, Assistant Professor, Department of Neurological Surgery, University of Wisconsin-Madison, Madison, WI
Behnam Badie, M.D., is a nationally recognized expert in neurosurgical oncology and the chief of neurosurgery City of Hope® Cancer Center Duarte, where he has performed thousands of brain tumor surgeries and led groundbreaking clinical trials that explore new ways to deliver treatments directly into the brain. Dr. Badie is also the Heritage Provider Network professor in gene therapy and the co-director of the Brain Tumor Program.
Dr. Badie specializes in the surgical treatment of both cancerous and non-cancerous brain conditions, including gliomas, pituitary tumors, meningiomas, acoustic neuromas and tumors found at the base of the skull and top of the spinal cord. While his top priority is always patient care, he also runs an active research program focused on discovering new treatment options for brain tumors. Much of his work centers on immunotherapy, which uses the body’s own immune system to fight cancer. He is currently leading clinical trials testing CAR T cell therapies for aggressive brain tumors, while his team is developing new methods to activate the brain’s immune cells using targeted nanoparticles. His research is funded by the National Cancer Institute (NCI) and other leading oncology research organizations.
Dr. Badie has published over 125 scientific papers in leading medical journals, such as the New England Journal of Medicine, Cancer Discovery and JAMA Oncology. He contributes his expertise to national advisory boards, including the NCI Experimental Therapeutics Program, and regularly serves as a reviewer for research panels at the National Institutes of Health. He is also a member of top professional groups like the American Association of Neurological Surgeons, the Congress of Neurological Surgeons and the Society for Neuro-Oncology. Since 2002, he has been consistently recognized in Top Doctors of America and America’s Top Doctors for Cancer lists.
Dr. Badie is dedicated to offering patients the most advanced, personalized care available—whether in the operating room, the clinic or through research that pushes the boundaries of what’s possible in cancer care.